NCT07094685
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07094685
Title Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer (SENIOR-HN)
Acronym SENIOR-HN
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Michigan Rogel Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Comprehensive Cancer Center RECRUITING Ann Arbor Michigan 48109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field